Private joint-stock company Farmak, a pharmaceutical company from Kyiv, is mulling a possibility of exporting own substances to the countries of the European Union (EU), Farmak Chief Operating Officer Pavlo Pavlyk has said.
“There are a number of projects with European companies. There are a number of orders. We are now looking at innovative substances in order to develop and produce them for the EU countries,” he told reporters on Monday.
Pavlyk also said that in May-June 2020, Farmak expects an FDA inspection, which will allow the company to supply drugs to the U.S. market.
Farmak is one of the three leaders of the pharmaceutical industry of Ukraine. It is a member of the Association Manufacturers of Medications of Ukraine (AMMU). The company’s beneficiary is head of the supervisory board Filia Zhebrovska.
© 2016-2025, Open4Business. All rights reserved.
All news and diagrams placed on this Web site is made for internal use. Its reproduction or distribution in any form are welcome in case of placing a direct hyperlink to a source. Reproduction or distribution of information which contains Interfax-Ukraine as a source is prohibited without the written permission from the Interfax-Ukraine news agency. Photoes placed on this site are taken from open sources only; rightholder are welcome to make demands to info@open4business.com.ua , in this case we are ready to put your copyright to a photo or replace it.